Price $61.20 |
Market Cap
3.21B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
142.0
|
P/B
4.25
|
P/S
3.72
|
Dividend %
-
|
|
P/CF
574.2
|
P/FCF
412.3
|
Op. Cash Flow
63.2K
|
FCF
0.1
|
|
Op. Margin
4.70%
|
Net Margin
2.40%
|
ROE
2.80%
|
ROI
4.00%
|
|
ROA
1.60%
|
EPS Growth
-45.70%
|
Current Ratio
2.7
|
Debt/Equity
38.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Endo International PLC (ENDP) | $16.29 | - | - | 3.74B | Strong Buy |
| Vaxart Inc (VXRT) | $3.03 | - | - | 21.9M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $4.30 | - | - | 32M | Strong Buy |
| Procyon Corp (PCYN) | $0.28 | - | - | 2M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $5.88 | - | - | 96.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
